Bone material properties in trabecular bone from human iliac crest biopsies after 3-and 5-year treatment with risedronate

被引:90
作者
Durchschlag, Erich
Paschalis, Eleftherios P.
Zoehrer, Ruth
Roschger, Paul
Fratzl, Peter
Recker, Robert
Phipps, Roger
Klaushofer, Klaus
机构
[1] Hanusch Hosp, Ludwig Boltzmann Inst Osleol, WGKK & AUVA Trauma Ctr Meidling, Med Dept 4, A-1140 Vienna, Austria
[2] Max Planck Inst Colloids & Interfaces, Dept Biomat, Berlin, Germany
[3] Creighton Univ, Osteoporosis Res Ctr, Omaha, NE 68178 USA
[4] Procter & Gamble Pharmaceut, Mason, OH USA
关键词
long-term risedronate treatment; postmenopausal osteoporosis; Fourier transform infrared imaging; mineral maturity/crystallinity; collagen cross-links;
D O I
10.1359/JBMR.060701
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Long-term effects of risedronate on bone mineral maturity/crystallinity and collagen cross-link ratio in triple iliac crest biopsies of osteoporotic women were evaluated. In this double-blinded study, 3- and 5-year treatment with risedronate arrested the tissue aging encountered in untreated osteoporosis and in osteoporosis treated with other antiresorptives. This effect may be contributing to risedronate's antifracture efficacy.
引用
收藏
页码:1581 / 1590
页数:10
相关论文
共 58 条
[1]   Optimal methods for processing mineralized tissues for Fourier transform infrared microspectroscopy [J].
Aparicio, S ;
Doty, SB ;
Camacho, NP ;
Paschalis, EP ;
Spevak, L ;
Mendelsohn, R ;
Boskey, AL .
CALCIFIED TISSUE INTERNATIONAL, 2002, 70 (05) :422-429
[2]   POSTTRANSLATIONAL MODIFICATIONS IN THE COLLAGEN OF HUMAN OSTEOPOROTIC FEMORAL-HEAD [J].
BAILEY, AJ ;
WOTTON, SF ;
SIMS, TJ ;
THOMPSON, PW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 185 (03) :801-805
[3]   BIOCHEMICAL-CHANGES IN THE COLLAGEN OF HUMAN OSTEOPOROTIC BONE-MATRIX [J].
BAILEY, AJ ;
WOTTON, SF ;
SIMS, TJ ;
THOMPSON, PW .
CONNECTIVE TISSUE RESEARCH, 1993, 29 (02) :119-132
[4]   Spectroscopically determined collagen Pyr/deH-DHLNL cross-link ratio and crystallinity indices differ markedly in recombinant congenic mice with divergent calculated bone tissue strength [J].
Blank, RD ;
Baldini, TH ;
Kaufman, M ;
Bailey, S ;
Gupta, R ;
Yershov, Y ;
Boskey, AL ;
Coppersmith, SN ;
Demant, P ;
Paschalis, EP .
CONNECTIVE TISSUE RESEARCH, 2003, 44 (3-4) :134-142
[5]   Risedronate preserves trabecular architecture and increases bone strength in vertebra of ovariectomized minipigs as measured by three-dimensional microcomputed tomography [J].
Borah, B ;
Dufresne, TE ;
Chmielewski, PA ;
Gross, GJ ;
Prenger, MC ;
Phipps, RJ .
JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 (07) :1139-1147
[6]   Risedronate preserves bone architecture in postmenopausal women with osteoporosis as measured by three-dimensional microcomputed tomography [J].
Borah, B ;
Dufresne, TE ;
Chmielewski, PA ;
Johnson, TD ;
Chines, A ;
Manhart, MD .
BONE, 2004, 34 (04) :736-746
[7]   THE INFLUENCE OF HIGH-MOLECULAR-WEIGHT AND LOW-MOLECULAR-WEIGHT INHIBITORS ON DISSOLUTION KINETICS OF HYDROXYAPATITE AND HUMAN-ENAMEL IN LACTATE BUFFERS - A CONSTANT COMPOSITION STUDY [J].
BUDZ, JA ;
RE, ML ;
NANCOLLAS, GH .
JOURNAL OF DENTAL RESEARCH, 1988, 67 (12) :1493-1498
[8]   Clinical use of bone densitometry - Scientific review [J].
Cummings, SR ;
Bates, D ;
Black, DM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (15) :1889-1897
[9]   ARE PATIENTS WITH HIP-FRACTURES MORE OSTEOPOROTIC - REVIEW OF THE EVIDENCE [J].
CUMMINGS, SR .
AMERICAN JOURNAL OF MEDICINE, 1985, 78 (03) :487-494
[10]  
DODDS RA, 1987, OSTEOPOROSIS 1987, P309